This protective/modulatory effect of sTWEAK on TNFα activity has been observed in such pathologies as rheumatoid arthritis [42], ischemic stroke [43] and several tumour epithelial cell lines [44], suggesting general competitive behaviour between sTWEAK and TNFα. This evidence concerns the gene TNF and neoplasm.